Moderna Extends Rally With Another Vaccine in the Works
- Stock touches intraday record after latest vaccine update
- Coronavirus and CMV vaccine updates fuel rally in shares
This article is for subscribers only.
On the heels of its biggest one-day gain Tuesday, Moderna Inc. touched an intraday record after revealing the development of an experimental vaccine for a virus tied to birth defects is advancing faster than expected.
That’s the second piece of good news for the biotech this week, which surged 28% yesterday after revealing that vials of a vaccine for the coronavirus had been shipped to the National Institutes of Health’s National Institute of Allergy and Infectious Diseases for clinical testing.